BETMAT launches endotoxin testing platform aimed at higher assay precision

BETMAT Biotechnology LLC introduced an integrated bacterial endotoxin testing platform built around kinetic incubating microplate readers and pyrogen-free microplates. The company says the system is designed to improve quantitative accuracy, reduce variability, and support regulated labs facing stricter quality and compliance demands.

Why it matters: - Bacterial endotoxin testing is a required control in pharmaceutical, biopharmaceutical, medical device, and clinical diagnostics work. - BETMAT’s platform is aimed at reducing false positives, optical interference, and assay variability that can disrupt quality control and batch release decisions. - Better precision can also reduce re-testing, investigation time, and manufacturing delays.

What happened: - BETMAT Biotechnology LLC announced advanced kinetic incubating microplate readers paired with pyrogen-free microplates for quantitative endotoxin testing. - The company said the platform is designed for seamless integration with high-precision optical detection systems. - BETMAT said the system is intended to support laboratories that need more stable, reproducible data in bacterial endotoxin applications. - More information is available on the company’s website.

The details: - The system is built around kinetic photometric methods, which are favored over older gel-clot testing for higher sensitivity, lower detection limits, and automation. - BETMAT said its microplates are manufactured under cleanroom-controlled conditions. - Each microplate is certified to contain endotoxin levels well below the detection thresholds of sensitive kinetic assays. - The plates are designed to reduce surface irregularities, material inconsistency, and optical interference. - BETMAT said the well bottoms are highly uniform to minimize light scattering and stabilize baseline readings across all 96 wells. - The accompanying readers support a measurement range from 0 to 4.0 OD. - The incubation design is built to maintain temperature accuracy of ± 0.2°C. - The system is designed to reduce edge effects that can cause uneven reaction kinetics across a plate. - BETMAT said the consumables work with Kinetic Turbidimetric Assay, Kinetic Chromogenic Assay, and recombinant Cascade Reagent testing. - The BETPro96X system described by BETMAT supports wavelengths from 340 nm to 1000 nm and multiple quantitative protocols. - The software workstation includes multi-level user access controls, audit trails, and secure electronic signature workflows. - The data analysis workflow is designed to support FDA 21 CFR Part 11 and EU Annex 11 compliance. - BETMAT said the system can support standard curve linear correlation coefficients at or above 0.99 and low assay coefficient of variation.

Between the lines: - The announcement reflects a broader shift in endotoxin testing from manual methods to automated quantitative workflows. - BETMAT is positioning the consumable and instrument as a matched system, not separate products. - That approach suggests the company sees plate quality and reader performance as equally important to assay accuracy. - The focus on pyrogen-free consumables also points to a growing concern that contamination can originate outside the sample itself.

What's next: - BETMAT is directing users to its website for product specifications and application notes. - Labs evaluating endotoxin workflows will likely compare the platform against existing readers, plates, and compliance requirements before adoption.

The bottom line: - BETMAT is pitching endotoxin testing as a systems problem, where microplates, optics, incubation, and software all affect the final result.